Stay updated on Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.

Latest updates to the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page; no substantive content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA consolidated Locations section is added listing study sites in California, Colorado, Florida, Massachusetts, New York, North Carolina, Ohio, Oregon, Texas, Ontario, and Quebec. Previous per-location pages were removed and the study record revision updated to v3.3.3.SummaryDifference0.8%

- Check53 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed and may not be about the study, and the Revision line has changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the government funding operating-status notice from the page; the content now presents only the study details without that disclaimer.SummaryDifference0.2%

- Check75 days agoChange DetectedThere are no significant changes to core study information between screenshots; the page content remains the same and any differences are limited to minor formatting or collapsed sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check104 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference2%

Stay in the know with updates to Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.